Find your next paid study

University of Southern CaliforniaNCT07836712

~$75 – $2,000

Actual pay is set by the research site.

Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis

The purpose of this study is to identify potential markers for curve progression in adolescent idiopathic scoliosis (AIS). Despite its prevalence and impact on…

Adolescent Idiopathic Scoliosis

University of Colorado, DenverNCT02315729

~$10 – $750

Actual pay is set by the research site.

Muscle-Invasive Bladder CarcinomaGastroesophageal AdenocarcinomaMelanoma+1 more

Phase 1 Clinical Trial of a Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

This is a phase 1 clinical trial to evaluate the safety, feasibility and immunogenicity of a personalized cancer vaccine strategy in patients with solid tumors…

Washington University School of MedicineNCT06529822

~$150 – $3,000

Actual pay is set by the research site.

DepressionCancerAdolescent+2 more

R00 Full Factorial Trial: Optimizing ASCENT

Our team has developed a digital intervention that aims to help adolescent and young adult cancer survivors (AYAs) manage symptoms of depression. This tool inc…

East Carolina UniversityNCT07173205

~$10 – $750

Actual pay is set by the research site.

In Vivo Testing : A Two-Arm, Randomized, Controlled, Investigator/Assessor-Blinded, Comparative Study to Evaluate the Safety, Efficacy, and Preventative Effect of a Head Lice Physically Acting Product: 2 in 1 SHAMPOO EU VERSION (X92001483) vs NIX CREME RINSE (1% Permethrin) in Subjects With Head Lice.

To compare the safety, effectiveness, and preventive benefits of a medical device (X92001483) against Nix Cream Rinse (1% Permethrin) in people with head lice

Lice; Head Lice

Oystershell NVNCT07660354

~$10 – $1,125

Actual pay is set by the research site.

Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)

The SCORE-NHL study is a prospective, multi-center, study designed to collect data and biological samples from participants diagnosed with aggressive Stage I t…

Non-Hodgkin LymphomaT-Cell LymphomaDiffuse Large B-Cell Lymphoma+7 more

~$10 – $1,050

Actual pay is set by the research site.

Natera, Inc.NCT07750886

Hot Weather; Adverse EffectHeat EffectHeat Stress+3 more

Beat the Heat: Impacts of Heat on Health in Boston and Strategies to Address Them

The goal of this stepped wedge trial is to assess the practical effects of air conditioners on hot weather impacts among older adults. The main questions it ai…

Harvard School of Public Health (HSPH)NCT06982339

~$10 – $675

Actual pay is set by the research site.

Advanced Malignant Solid NeoplasmClinical Stage III Gastroesophageal Junction AdenocarcinomaClinical Stage IV Gastroesophageal Junction Adenocarcinoma+26 more

A Phase I Study of Trifluridine/ Tipiracil Plus the Poly (ADP) Ribose Polymerase Inhibitor Talazoparib in Advanced Cancers

This phase I trial investigates the side effects and best dose of talazoparib when given together with trifluridine/tipiracil for the treatment of patients wit…

Radiation NecrosisCerebral Edema

Transcutaneous Auricular Vagal Nerve Stimulation for Treatment of Radiation Necrosis

This is a multi-center, randomized, blinded trial evaluating the effect of transcutaneous auricular vagal nerve stimulator (taVNS) on radiation necrosis-relate…

Virginia Commonwealth UniversityNCT07680127

~$10 – $750

Actual pay is set by the research site.

Pediatric DisorderGenetic PredispositionDystonia, Secondary+5 more

Pharmacogenomic Contribution to the Biotransformation of Trihexyphenidyl and Development of a Precision Dosing Model for Children With Dystonia and Cerebral Palsy

This study looks at how a medicine called trihexyphenidyl works in children with dystonic cerebral palsy. The study aims to understand how trihexyphenidyl is b…

Children's Mercy Hospital Kansas CityNCT06554288

~$150 – $3,000

Actual pay is set by the research site.

Advanced or Metastatic Solid TumorsBreast CancerOvarian Cancer+10 more

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

This is a two-part, open-label, multicenter, dose escalation and dose expansion study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pha…

858 Therapeutics, Inc.NCT06395519

~$150 – $4,200

Actual pay is set by the research site.

Phase 2

Repurposing Riluzole for Augmenting Brain-Derived Neuropathic Factor (BDNF) Levels and Cognitive Function in Patients Experiencing Cancer-Related Cognitive Impairment: An Interventional Pilot Clinical Trial

This is a phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining the impact of riluzole therapy on circulating brain derived…

Breast CancerSarcomaGastric Cancer+19 more